(Q44701875)

5 December 2017

title

Significance of p53, Bcl-2, and HER-2/neu protein expression in Omani Arab females with breast cancer (English)

1 reference

5 December 2017

0 references

Mansour Al-Moundhri

1

1 reference

5 December 2017

V Nirmala

2

1 reference

5 December 2017

K Al-Mawaly

3

1 reference

5 December 2017

S Ganguly

4

1 reference

5 December 2017

I Burney

5

1 reference

5 December 2017

A Rizvi

6

1 reference

5 December 2017

C Grant

7

1 reference

5 December 2017

publication date

22 December 2003

1 reference

Pathology Oncology Research

5 December 2017

published in

1 reference

5 December 2017

volume

9

1 reference

5 December 2017

issue

4

1 reference

5 December 2017

page(s)

226-231

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02893382

5 December 2017

exact match

0 references

cites work

Proliferation in African breast cancer: biology and prognostication in nigerian breast cancer material.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02893382

Clinical relevance of immunohistochemical expression of p53-targeted gene products mdm-2, p21 and bcl-2 in breast carcinoma

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02893382

Prognostic value of bcl-2 expression in invasive breast cancer

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02893382

Unique features of breast cancer in Taiwan

21 January 2018

1 reference

12 December 2020

Down-regulation of bcl-2 by p53 in breast cancer cells.

1 reference

12 December 2020

p53 expression is of independent predictive value in lymph node-negative breast carcinoma

1 reference

12 December 2020

Breast cancer in Tunisia: clinical and epidemiological study

1 reference

12 December 2020

Relationship between c-erbB-2 and other tumor characteristics in breast cancer prognosis

1 reference

12 December 2020

Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters

1 reference

12 December 2020

erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer

1 reference

12 December 2020

Current status of breast cancer in Hong Kong

1 reference

12 December 2020

Expression of cellular oncogenes in human malignancies

1 reference

12 December 2020

Overexpression of the Bcl-2 Protein Increases the Half-life of p21Bax

1 reference

12 December 2020

The HER2 extracellular domain as a prognostic and predictive factor in breast cancer

1 reference

12 December 2020

Racial differences in breast cancer survival: the interaction of socioeconomic status and tumor biology

1 reference

12 December 2020

Cancer incidence in Oman, 1993-1997

1 reference

12 December 2020

Immunohistochemical expression of Bcl-2 protein in breast lesions: correlation with Bax, p53, Rb, C-erbB-2, EGFR and proliferation indices

1 reference

12 December 2020

Breast cancer: patient characteristics and survival analysis at Salmaniya medical complex, Bahrain

1 reference

12 December 2020

The prevalence of BCL-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status

1 reference

12 December 2020

Prognostic indicators for breast cancer patients with one to three regional lymph node metastases, with special reference to alterations in expression levels of bcl-2, p53 and c-erbB-2 proteins

1 reference

12 December 2020

Abnormal p53 immunoreactivity and prognosis in node-negative breast carcinomas with long-term follow-up

1 reference

12 December 2020

The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients.

1 reference

12 December 2020

Biologic and clinical significance of HER-2/neu (cerbB-2) in breast cancer

1 reference

12 December 2020

Bcl-2 and p53 expression in node-negative breast carcinoma: A study with long-term follow-up

1 reference

12 December 2020

Relevance of the expression of bcl-2 in combination with p53 as a prognostic factor in breast cancer

1 reference

12 December 2020

Immunohistochemical detection of p53 protein expression in breast cancer in young Kuwaiti women

1 reference

12 December 2020

Loss of bcl-2 expression in ductal carcinoma in situ of the breast relates to poor histological differentiation and to expression of p53 and c-erbB-2 proteins.

1 reference

12 December 2020

Bcl-2 has a cell cycle inhibitory function separable from its enhancement of cell survival

1 reference

12 December 2020

Multivariate analysis of bcl-2, apoptosis, P53 and HER-2/neu in breast cancer: a short-term follow-up.

1 reference

12 December 2020

The lack of age as a significant prognostic factor in non-metastatic breast cancer.

1 reference

12 December 2020

Clinico-pathological features of breast cancer in Pakistan

1 reference

12 December 2020

The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy.

1 reference

12 December 2020

Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers

1 reference

12 December 2020

c-myc, p53 and bcl-2, apoptosis-related genes in infiltrating breast carcinomas: evidence of a link between bcl-2 protein over-expression and a lower risk of metastasis and death in operable patients

1 reference

12 December 2020

Tumor biology and prognosis in black breast cancer patients: a review

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02893382

1 reference

5 December 2017

1 reference